James E Flynn Insider Trading Transactions
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in SALIX PHARMACEUTICALS LTD ($SLXP) and 10% Owner in ANADYS PHARMACEUTICALS INC ($ANDS) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Invitae Corp ($NVTA).
Latest Insider Trading Transactions of James E Flynn
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANDS, AUXL, CAMY.OB, DRNA, EHTH, NVTA, PRX, TARA, SLXP, VNDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2015 | NVTA | Invitae Corp | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
Feb 19 2015 | NVTA | Invitae Corp | Flynn James E | 10% Owner | Buy | P | 16.00 | 48,388 | 774,208 | 48,388 | 0 to 48.4 K |
Feb 19 2015 | NVTA | Invitae Corp | Flynn James E | 10% Owner | Buy | P | 16.00 | 39,112 | 625,792 | 39,112 | 0 to 39.1 K |
Feb 19 2015 | NVTA | Invitae Corp | Flynn James E | 10% Owner | Buy | P | 16.00 | 87,500 | 1,400,000 | 254,166 | 166.7 K to 254.2 K (+52.50 %) |
Feb 19 2015 | NVTA | Invitae Corp | Flynn James E | 10% Owner | Buy | C | 0.00 | 166,666 | 0 | 166,666 | 0 to 166.7 K |
Feb 02 2015 | AUXL | AUXILIUM PHARMACEU ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 3,469,974 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
Feb 02 2015 | AUXL | AUXILIUM PHARMACEU ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 2,797,408 | 0 | 0 | 2.8 M to 0 (-100.00 %) |
Jan 16 2015 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.45 | 420,280 | 8,594,726 | 1,804,903 | 1.4 M to 1.8 M (+30.35 %) |
Jan 16 2015 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.45 | 339,720 | 6,947,274 | 1,459,685 | 1.1 M to 1.5 M (+30.33 %) |
Jan 16 2015 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.84 | 132,720 | 2,632,501 | 1,384,623 | 1.3 M to 1.4 M (+10.60 %) |
Jan 16 2015 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.84 | 107,280 | 2,127,899 | 1,119,965 | 1 M to 1.1 M (+10.59 %) |
Jan 05 2015 | CAMY.OB | CAS MEDICAL SYSTEM ... | Flynn James E | 10% Owner | Sell | S | 1.65 | 1,443,200 | 2,381,280 | 0 | 1.4 M to 0 (-100.00 %) |
Jan 05 2015 | CAMY.OB | CAS MEDICAL SYSTEM ... | Flynn James E | 10% Owner | Buy | P | 1.65 | 1,443,200 | 2,381,280 | 3,200,000 | 1.8 M to 3.2 M (+82.15 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.48 | 20,580 | 297,998 | 1,674,781 | 1.7 M to 1.7 M (+1.24 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.48 | 16,434 | 237,964 | 1,346,715 | 1.3 M to 1.3 M (+1.24 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.30 | 13,900 | 198,770 | 1,654,201 | 1.6 M to 1.7 M (+0.85 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.30 | 11,100 | 158,730 | 1,330,281 | 1.3 M to 1.3 M (+0.84 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.33 | 11,120 | 159,350 | 1,640,301 | 1.6 M to 1.6 M (+0.68 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.33 | 8,880 | 127,250 | 1,319,181 | 1.3 M to 1.3 M (+0.68 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.50 | 13,900 | 201,550 | 1,629,181 | 1.6 M to 1.6 M (+0.86 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.50 | 11,100 | 160,950 | 1,310,301 | 1.3 M to 1.3 M (+0.85 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.48 | 16,680 | 241,526 | 1,615,281 | 1.6 M to 1.6 M (+1.04 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.48 | 13,320 | 192,874 | 1,299,201 | 1.3 M to 1.3 M (+1.04 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.23 | 13,900 | 197,797 | 1,598,601 | 1.6 M to 1.6 M (+0.88 %) |
Dec 24 2014 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 14.23 | 11,100 | 157,953 | 1,285,881 | 1.3 M to 1.3 M (+0.87 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.50 | 55,035 | 632,903 | 800,794 | 855.8 K to 800.8 K (-6.43 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.50 | 48,027 | 552,311 | 698,822 | 746.8 K to 698.8 K (-6.43 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.50 | 18,903 | 217,385 | 275,046 | 293.9 K to 275 K (-6.43 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.54 | 3,785 | 43,679 | 855,829 | 859.6 K to 855.8 K (-0.44 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.54 | 3,303 | 38,117 | 746,849 | 750.2 K to 746.8 K (-0.44 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.55 | 14,199 | 163,998 | 293,949 | 308.1 K to 293.9 K (-4.61 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.55 | 41,339 | 477,465 | 859,614 | 901 K to 859.6 K (-4.59 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.55 | 36,074 | 416,655 | 750,152 | 786.2 K to 750.2 K (-4.59 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.54 | 1,300 | 15,002 | 308,148 | 309.4 K to 308.1 K (-0.42 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.00 | 45,124 | 496,364 | 900,953 | 946.1 K to 901 K (-4.77 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.00 | 39,377 | 433,147 | 786,226 | 825.6 K to 786.2 K (-4.77 %) |
Nov 25 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.00 | 15,499 | 170,489 | 309,448 | 324.9 K to 309.4 K (-4.77 %) |
Nov 10 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 9.33 | 30,100 | 280,833 | 0 | 30.1 K to 0 (-100.00 %) |
Nov 10 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 9.27 | 3,500 | 32,445 | 30,100 | 33.6 K to 30.1 K (-10.42 %) |
Nov 10 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 9.00 | 180,564 | 1,625,076 | 33,600 | 214.2 K to 33.6 K (-84.31 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | J | 0.00 | 838,067 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | J | 0.00 | 1,049,472 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | J | 0.00 | 4,907,601 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,047,584 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,311,840 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 6,134,501 | 0 | 0 | |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 45 | 450 | 170,371 | 170.3 K to 170.4 K (+0.03 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 55 | 550 | 208,345 | 208.3 K to 208.3 K (+0.03 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 272 | 2,720 | 170,326 | 170.1 K to 170.3 K (+0.16 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 328 | 3,280 | 208,290 | 208 K to 208.3 K (+0.16 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 12,819 | 128,190 | 170,054 | 157.2 K to 170.1 K (+8.15 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 15,417 | 154,170 | 207,962 | 192.5 K to 208 K (+8.01 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 5,801 | 58,010 | 157,235 | 151.4 K to 157.2 K (+3.83 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 6,976 | 69,760 | 192,545 | 185.6 K to 192.5 K (+3.76 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 81,949 | 819,490 | 151,434 | 69.5 K to 151.4 K (+117.94 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 98,556 | 985,560 | 185,569 | 87 K to 185.6 K (+113.27 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | P | 10.00 | 469,495 | 4,694,950 | 876,391 | 406.9 K to 876.4 K (+115.38 %) |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 69,485 | 0 | 69,485 | 0 to 69.5 K |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 87,013 | 0 | 87,013 | 0 to 87 K |
Oct 27 2014 | PRTO | PROTEON THERAPEUTI ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 406,896 | 0 | 406,896 | 0 to 406.9 K |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 10.01 | 51,449 | 515,004 | 214,164 | 265.6 K to 214.2 K (-19.37 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.02 | 14,464 | 159,393 | 946,077 | 960.5 K to 946.1 K (-1.51 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.02 | 12,622 | 139,094 | 825,603 | 838.2 K to 825.6 K (-1.51 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.02 | 4,061 | 44,752 | 265,613 | 269.7 K to 265.6 K (-1.51 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 11.02 | 4,968 | 54,747 | 324,947 | 329.9 K to 324.9 K (-1.51 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.00 | 246 | 2,952 | 960,541 | 960.8 K to 960.5 K (-0.03 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.00 | 215 | 2,580 | 838,225 | 838.4 K to 838.2 K (-0.03 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.00 | 69 | 828 | 269,674 | 269.7 K to 269.7 K (-0.03 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.00 | 84 | 1,008 | 330 | 414 to 330 (-20.29 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.14 | 11,855 | 143,860 | 960,787 | 972.6 K to 960.8 K (-1.22 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.14 | 10,345 | 125,537 | 838,440 | 848.8 K to 838.4 K (-1.22 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.14 | 3,328 | 40,385 | 269,743 | 273.1 K to 269.7 K (-1.22 %) |
Oct 15 2014 | DRNA | Dicerna Pharmaceut ... | Flynn James E | 10% Owner | Sell | S | 12.14 | 4,072 | 49,414 | 329,999 | 334.1 K to 330 K (-1.22 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.16 | 133,445 | 1,756,136 | 2,941,480 | 3.1 M to 2.9 M (-4.34 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.16 | 66,555 | 875,864 | 1,928,520 | 2 M to 1.9 M (-3.34 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 33,361 | 435,695 | 3,074,925 | 3.1 M to 3.1 M (-1.07 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 16,639 | 217,305 | 1,995,075 | 2 M to 2 M (-0.83 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.01 | 200,168 | 2,604,186 | 3,108,286 | 3.3 M to 3.1 M (-6.05 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.01 | 99,832 | 1,298,814 | 2,011,714 | 2.1 M to 2 M (-4.73 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.49 | 64,720 | 873,073 | 3,308,454 | 3.4 M to 3.3 M (-1.92 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.49 | 32,280 | 435,457 | 2,111,546 | 2.1 M to 2.1 M (-1.51 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 41,980 | 548,259 | 3,373,174 | 3.4 M to 3.4 M (-1.23 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.06 | 20,937 | 273,437 | 2,143,826 | 2.2 M to 2.1 M (-0.97 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.32 | 22,782 | 303,456 | 3,415,154 | 3.4 M to 3.4 M (-0.66 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.32 | 11,361 | 151,329 | 2,164,763 | 2.2 M to 2.2 M (-0.52 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 145,704 | 1,891,238 | 3,437,936 | 3.6 M to 3.4 M (-4.07 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.96 | 25,000 | 324,000 | 3,583,640 | 3.6 M to 3.6 M (-0.69 %) |
Sep 10 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 111,189 | 1,443,233 | 3,608,640 | 3.7 M to 3.6 M (-2.99 %) |
Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 10,921 | 141,755 | 3,719,829 | 3.7 M to 3.7 M (-0.29 %) |
Aug 20 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.96 | 70,000 | 907,200 | 3,730,750 | 3.8 M to 3.7 M (-1.84 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.55 | 14,852 | 186,393 | 3,800,750 | 3.8 M to 3.8 M (+0.39 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.55 | 9,901 | 124,258 | 2,176,124 | 2.2 M to 2.2 M (-0.45 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | S | 12.98 | 113,182 | 1,469,102 | 3,815,602 | 3.7 M to 3.8 M (+3.06 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 12.98 | 75,448 | 979,315 | 2,186,025 | 2.3 M to 2.2 M (-3.34 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 86,540 | 1,134,539 | 3,928,784 | 4 M to 3.9 M (-2.16 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 13.11 | 57,689 | 756,303 | 2,261,473 | 2.3 M to 2.3 M (-2.49 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.50 | 6,100 | 106,750 | 2,108,213 | 2.1 M to 2.1 M (-0.29 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.48 | 31,845 | 556,651 | 2,114,313 | 2.1 M to 2.1 M (-1.48 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.66 | 103,900 | 1,834,874 | 2,146,158 | 2.3 M to 2.1 M (-4.62 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.93 | 18,009 | 322,901 | 2,250,058 | 2.3 M to 2.3 M (-0.79 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.81 | 35,000 | 623,350 | 2,268,067 | 2.3 M to 2.3 M (-1.52 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.85 | 1,700 | 30,345 | 2,303,067 | 2.3 M to 2.3 M (-0.07 %) |
Aug 19 2009 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 17.47 | 43,862 | 766,269 | 2,304,767 | 2.3 M to 2.3 M (-1.87 %) |
Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 21,588 | 184,362 | 3,957,249 | 3.9 M to 4 M (+0.55 %) |
Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 12,462 | 106,425 | 2,285,637 | 2.3 M to 2.3 M (+0.55 %) |
Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.87 | 22,190 | 196,825 | 3,935,661 | 3.9 M to 3.9 M (+0.57 %) |
Jan 02 2009 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.87 | 12,810 | 113,625 | 2,273,175 | 2.3 M to 2.3 M (+0.57 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 381 | 3,254 | 3,717,944 | 3.7 M to 3.7 M (+0.01 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 219 | 1,870 | 2,147,492 | 2.1 M to 2.1 M (+0.01 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.33 | 3,424 | 28,522 | 3,717,563 | 3.7 M to 3.7 M (+0.09 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.33 | 1,976 | 16,460 | 2,147,273 | 2.1 M to 2.1 M (+0.09 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.40 | 57,061 | 479,312 | 3,714,139 | 3.7 M to 3.7 M (+1.56 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.40 | 32,939 | 276,688 | 2,145,297 | 2.1 M to 2.1 M (+1.56 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 28,471 | 243,142 | 3,657,078 | 3.6 M to 3.7 M (+0.78 %) |
Dec 24 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.54 | 16,435 | 140,355 | 2,112,358 | 2.1 M to 2.1 M (+0.78 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.48 | 54,409 | 461,388 | 3,628,607 | 3.6 M to 3.6 M (+1.52 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.48 | 31,409 | 266,348 | 2,095,523 | 2.1 M to 2.1 M (+1.52 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.53 | 9,570 | 81,632 | 3,574,198 | 3.6 M to 3.6 M (+0.27 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.53 | 5,524 | 47,120 | 2,064,514 | 2.1 M to 2.1 M (+0.27 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 20,289 | 171,848 | 3,564,628 | 3.5 M to 3.6 M (+0.57 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 11,711 | 99,192 | 2,058,990 | 2 M to 2.1 M (+0.57 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 33,308 | 283,784 | 3,544,339 | 3.5 M to 3.5 M (+0.95 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 19,227 | 163,814 | 2,047,279 | 2 M to 2 M (+0.95 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.04 | 10,588 | 85,128 | 3,511,031 | 3.5 M to 3.5 M (+0.30 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.04 | 6,112 | 49,140 | 2,028,052 | 2 M to 2 M (+0.30 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 7.78 | 135,009 | 1,050,370 | 3,500,443 | 3.4 M to 3.5 M (+4.01 %) |
Dec 22 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 7.78 | 77,938 | 606,358 | 2,021,940 | 1.9 M to 2 M (+4.01 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 63,401 | 537,006 | 3,913,471 | 3.9 M to 3.9 M (+1.65 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 36,599 | 309,994 | 2,260,365 | 2.2 M to 2.3 M (+1.65 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 5,326 | 45,111 | 3,850,070 | 3.8 M to 3.9 M (+0.14 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.47 | 3,074 | 26,037 | 2,223,766 | 2.2 M to 2.2 M (+0.14 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 126,800 | 1,080,336 | 3,844,744 | 3.7 M to 3.8 M (+3.41 %) |
Dec 31 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 8.52 | 73,200 | 623,664 | 2,220,692 | 2.1 M to 2.2 M (+3.41 %) |
Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | S | 7.51 | 323,900 | 2,432,489 | 0 | |
Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | S | 7.51 | 178,100 | 1,337,531 | 0 | |
Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | J | 7.51 | 460,400 | 3,457,604 | 0 | |
Oct 21 2008 | SLXP | SALIX PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | J | 7.51 | 264,600 | 1,987,146 | 0 | |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.42 | 2,219 | 23,122 | 2,348,629 | 2.4 M to 2.3 M (-0.09 %) |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.42 | 1,281 | 13,348 | 1,355,787 | 1.4 M to 1.4 M (-0.09 %) |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.40 | 18,513 | 192,535 | 2,350,848 | 2.4 M to 2.4 M (-0.78 %) |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.40 | 10,687 | 111,145 | 1,357,068 | 1.4 M to 1.4 M (-0.78 %) |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.45 | 89,267 | 932,840 | 2,369,361 | 2.5 M to 2.4 M (-3.63 %) |
Dec 01 2008 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 10.45 | 51,533 | 538,520 | 1,367,755 | 1.4 M to 1.4 M (-3.63 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 136,907 | 298,457 | 904,903 | 1 M to 904.9 K (-13.14 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 74,693 | 162,831 | 493,713 | 568.4 K to 493.7 K (-13.14 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 157,486 | 343,319 | 1,077,165 | 1.2 M to 1.1 M (-12.76 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 90,914 | 198,193 | 659,711 | 750.6 K to 659.7 K (-12.11 %) |
Page: 1